Your shopping cart is currently empty

CDK7-IN-30 (Compound 22) is a potent CDK7 inhibitor (IC50=7.21 nM) that suppresses RNA polymerase II and CDK2 phosphorylation, induces apoptosis, and can be used in cancer research.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $293 | - | In Stock | |
| 5 mg | $722 | - | In Stock | |
| 10 mg | $987 | - | In Stock | |
| 25 mg | $1,520 | - | In Stock | |
| 50 mg | $1,980 | - | In Stock | |
| 100 mg | $2,500 | - | In Stock |
| Description | CDK7-IN-30 (Compound 22) is a potent CDK7 inhibitor (IC50=7.21 nM) that suppresses RNA polymerase II and CDK2 phosphorylation, induces apoptosis, and can be used in cancer research. |
| Targets&IC50 | CDK7:7.21 nM |
| In vitro | CDK7-IN-30 exhibits potent antiproliferative effects against cancer cells, with IC₅₀ values of 288.0 nM (RS4;11), 174.6 nM (MM.1S), 37.5 nM (Mino), and 168.7 nM (Jeko-1). Conversely, it exhibits minimal inhibition of normal blood cells (PBMCs) with an IC₅₀ of 757.9 nM [1]. CDK7-IN-30 (50-500 nM; 24 h) induced cell cycle arrest at the G1/S phase in MV4-11 cells. CDK7-IN-30 (100-1000 nM; 48 h) promoted apoptosis[1]. |
| Molecular Weight | 466 |
| Formula | C21H28ClN5O3S |
| Cas No. | 3040999-70-7 |
| Smiles | N(C1=C(S(C(C)C)(=O)=O)C=CC=C1)C2=NC(N[C@@H]3CC[C@@H](NC(C)=O)CC3)=NC=C2Cl |
| Storage | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.